Литература/References
1. Bertoldi A., De Crignis E., Miserocchi A., Bon I., at al. HIV and kidney: a dangerous liaison. New Microbiol. 2017; 40 (1): 1-10.
2. Hou J., Nast C.C. Changing concepts of HIV infection and renal disease. Curr Opin Nephrol Hypertens. 2018; 27 (3): 144-52.
3. Ryom L., Mocroft A., Kirk O., Ross M., et al. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. AIDS. 2014; 28: 187-99.
4. Ando M., Yanagisawa N. Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients. World J Nephrol. 2015; 4 (3): 388-95.
5. Achhra A.C., Nugent M., Mocroft A., Ryom L., at al. Chronic kidney disease and antiretroviral therapy in HIV-positive individuals: recent developments. Curr HIV/AIDS Rep. 2016; 13 (3): 149-57.
6. Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013; 3: 1-150.
7. Sereti I., Lane H.C. Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies. Clin Infect Dis. 2001; 32: 1738-55.
8. Moir S., Chun T.W., Fauci A.S. Pathogenic mechanisms of HIV disease. Annu Rev Pathol. 2011; 6: 223-48.
9. Scully E., Alter G. NK cells in HIV disease. Curr HIV/AIDS Rep. 2016; 13 (2): 85-94.
10. Doitsh G., Greene W.C. Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe. 2016; 19 (3): 280-91.
11. Conaldi P.G., Bottelli A., Wade-Evans A., Biancone L., Baj A., et al. HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis. AIDS. 2000; 14 (13): 2045-7.
12. Terzieva V.I., Popova D.N., Elenkov 1.1. IFN-γ attenuates spontaneous lymphocyte proliferation by fuelling regulatory T cells in HIV-1-infected patients. Viral Immunol. 2017; 30 (3): 157-66.
13. Strutz F., Neilson E.G. New insights into mechanism of fibrosis in immune renal injury. Springer Semin Immunopathol. 2003; 24: 459-76.
14. French M.A., Cozzi-Lepri A., Arduino R.C., Johnson M., Achhra A.C., Landay A. Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial. AIDS. 2015; 29 (7): 847-51.
15. Alefano M., Crotti A., Vicenzi E., Poli G. New players in cytokine control of HIV infection. Curr HIV/AIDS. 2008; 5: 27-32.
16. Mikulak J., Singhal P.C. HIV-1 and kidney cells: better understanding of viral interaction. Nephron Exp Nephrol. 2010; 115 (2): 15-21.
17. Madrigal-Jimenez H.M., Flores-Flores L., Carrillo Estrada F., et al. High levels of HIV-1 RNA associated with early-onset glomerulopathy in patients with HIV Infection. Mayo Clin Proc. 2007; 82 (9): 1103-16.
18. Wada T., Yokoyama H., Kobayashi K. Chemokines: new target molecules in renal diseases. Clin Exp Nephrol. 2000; 4: 273-80.
19. Bottinger E.P., Bitzer M. TGF-β signaling in renal disease. J Am Soc Nephrol. 2002; 13: 2600-10.
20. Paiardini M., Mdller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013; 254: 78-101.
21. Wang H., Li J., Gai Z., Kullak-Ublick G.A., et al. TNF-α deficiency prevents renal inflammation and oxidative stress in obese mice. Kidney Blood Press Res. 2017; 42 (3): 416-27.
22. Okon K. Tubulo-interstitial changes in glomerulopathy. Prognostic significance. Pol J Pathol. 2003; 4 (3): 163-9.
23. Estrella M.M., Fine D.M., Atta M.G. Recent developments in HIV-related kidney disease. HIV Ther. 2010; 4 (5): 589-603.
24. Naicker S., Rahmanian S., Kopp J.B. HIV and chronic kidney disease. Clin Nephrol. 2015; 83 (7): 32-8.